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Introduction
Cell based therapy requires great numbers of cells in a
functional state permitting their in vivo implantation for
the restoration of tissue homeostasis. Three main para-
meters are believed to be essential for such a purpose:
an appropriate cell population, a suitable scaffold and
appropriate physical / biochemical factors enabling
proper expansion and in vitro cell differentiation. In
recent years, mesenchymal stem cells (MSCs) have been
attracting a lot of interest in this field, because of their
differentiation potential and their trophic factor secre-
tion abilities. The aim of this work is to perform a
rational analysis of key factors involved in the efficient
proliferation and differentiation of MSCs, in the context
of a stirred microcarrier (MC)-based bioreactor.
Materials and methods
MSCs from external ear (E-MSCs) and bone marrow
stroma (BM-MSCs) were extracted from Wistar rats,
selected and cultivated on plastic dishes as previously
described [1]. The differentiation potential of E-MSCs
along the adipogenic, osteogenic and chondrogenic
pathways was established and assessed by staining
(respectively Oil red O, von Kossa, Alcian Blue) as well
as by RT-PCR analysis on marker genes of differentia-
tion (respectively, C/EBPa, osteocalcin, aggrecan) as
previously described [1]. MCs (i.e. Cultispher-S, Cyto-
dex-3, Cytopore-2) were prepared and cells were seeded
as reported in [2]. Cell counting was performed as fol-
lows: (1) after a full digestion of Cultispher-S by trypsin
and using trypan blue exclusion counting method, as in
[2]; (2) by crystal violet staining and nuclei counting for
Cytodex-3, as in [2]; or (3) cell counting on Cytopore-2
was performed using MTT according to [3]. The multi-
plication ratio was calculated as defined elsewhere [2].
Cell cycle was analyzed by FACS, after cell staining with
propidium iodide, as in [2]. The actin organization was
assed by confocal microscopy after cell staining with
phalloidin-rhodamine.
Results
MSC and microcarrier screening
E-MSCs were compared to the “gold standard” BM-
MSCs on the basis of their proliferative properties. E-
MSCs bear characteristics of progenitor cells: expression
of CD73, Sca-1 and Notch-1, and also in vitro differen-
tiation potential into mesodermal cell types such as adi-
pocytes, chondrocytes and osteoblasts (not shown).
Thus, these cells are in vitro functionally analogous to
BM-MSCs. This cell population was further selected on
the basis of its high intrinsic proliferation potential in
monolayer culture, a clear advantage in the field of
MSC bioprocessing (Table 1).
Next, we analyzed these cells’ behavior on various
types of MCs. Interestingly, both cell types (E- and BM-
MSCs) had similar proliferation profiles under all the
conditions tested: Cultispher-S>Cytodex-3>Cytopore-2
(Table 1). This validated that E-MSCs are a valuable
model for studying MSCs activities on MCs, given their
faster growth and easier handling compared to BM-
MSCs (Table 1). In addition, Cultispher-S turned out to
be the most efficient MC for MSC expansion (Table 1).
Maximization of MSC proliferation in MC-based stirred
bioreactors
According to Table 1, a batch culture mode was not
sufficient to promote efficient E-MSC propagation on
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Cultispher-S. Conversely, cyclic fed-batch increased E-
MSC growth span (Table 1). In addition, the use of high
levels of growth factors (using a pulsed culture com-
posed of 40% FBS and 1 ng/mL of TGFb1) increased
growth span (Table 1). The beneficial effects of cyclic
fed-batch and pulsed culture were linked to a sustain-
ment of the percentage of cells in S-phase of the cell
cycle compared to batch culture (Table 1). These results
Table 1 Multiplication ratios of E-MSCs and BM-MSCs on various culture systems. Multiplication ratios of E-MSCs and
percentage of cells in S-phase at day 5 of a 7 day run, under various modes of culture
MSC and MC screening
BM-MSCs Culture system Multiplication ratio
T-Flasks 0.4 ± 0.2
Cultispher-S 0.16 ± 0.1
Cytodex-3 -0.1 ± 0.12
Cytopore-2 -0.5 ± 0.04
E-MSCs T-Flasks 2.4 ± 0.1
Cultispher-S 2 ± 0.3
Cytodex-3 0.7 ± 0.6
Cytopore-2 -0.6 ± 0.3
Maximization of MSC proliferation
E-MSCs on Cultispher-S Mode of culture Multiplication ratio % of cells in S-phase at day 5
Batch 1.5 ± 0.3 1.4 ± 0.3
Cyclic-fed-batch 2.6 ± 0.2 8 ± 1
Pulsed culture 3 ± 0.04 15 ± 1
Figure 1 RT-PCR analysis of E-MSC differentiation. Spontaneous marker gene expression after MC expansion (control) (a); adipogenic
differentiation (C/EBPa as a marker) after MC expansion, adding an actin modulator in the differentiation medium (Y-27632 or LPA) (b);
osteogenic differentiation (osteocalcin as a marker) after MC expansion, adding an actin modulator in the differentiation medium (Y-27632 or
LPA); chondrogenic differentiation (aggrecan as a maker) after MC expansion, comparing Cultispher-S to Cytopore 2 (d)
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underline that the control of growth factor levels in the
medium is the key to maximize E-MSC growth extent.
Sequential proliferation and differentiation in MC-based
stirred bioreactors, modulating actin organization
We have previously shown that the addition of differen-
tiation media significantly diminished E-MSC prolifera-
tion. This indicated that the differentiation of E-MSCs
on MCs must be performed sequentially, after an initial
proliferation phase. According to Figure 1.b, after a first
step of E-MSC expansion on MCs, it was shown that
the repression of fibrillar actin (adding Y-27632 to the
differentiation medium) maximized adipogenic differen-
tiation on Cultispher-S, while the promotion of stress
fibers (using lysophosphatidic acid, LPA) diminished it.
In the same vein, Y-27632 improved E-MSC osteogenic
differentiation, while LPA lowered the expression of
osteocalcin (Figure 1.c). Cytopore-2, previously shown
to promote disorganized actin form (similar to that of
aggregate cultures and E-MSCs treated with cytochala-
sin-D), enabled an efficient E-MSC chondrogenic differ-
entiation, in comparison to Cultispher-S (Figure 1.d).
This latter MC was previously found to enable a proper
E-MSCs actin organization (composed of mixed cortical
and fibrillar actin) linked with their efficient propaga-
tion. These results indicate that a tight control of the E-
MSC microenvironment leading to adapted actin shape
is the key towards efficient MSC differentiation on
MCs.
Conclusions
According to these data, it emerges that a correct con-
trol of MSC microenvironment in terms of MC compo-
sition is necessary to promote these cells’ efficient
proliferation via proper actin organization. An efficient
MC system must also be combined with adapted bio-
chemical signaling. Indeed, the growth factor content is
an essential factor to monitor towards improved MSC
growth yield. As we observed that the differentiation
step could not be combined with expansion, sequential
phases are required for the mass scale production of a
given MSC differentiated phenotype. Similarly to the
expansion phase, the microenvironment to which MSCs
are exposed modulates the efficiency of their differentia-
tion. According to our results, the promotion of an ade-
quate actin organization is one of the essential
parameters enabling, in association to biochemical sig-
naling from the differentiation medium, efficient MSC
differentiation on MCs.
Taken together, these results open the way toward
mass scale production of MSCs suitable for future in
vivo applications.
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